Get the Stockscreener App
2.69
0.74%
-0.02
After Hours:
2.69
Inotiv Inc stock is traded at $2.69, with a volume of 480.66K.
It is down -0.74% in the last 24 hours and up +52.84% over the past month.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
See More
Previous Close:
$2.71
Open:
$2.82
24h Volume:
480.66K
Relative Volume:
0.64
Market Cap:
$92.40M
Revenue:
$501.06M
Net Income/Loss:
$-99.22M
P/E Ratio:
-0.7005
EPS:
-3.84
Net Cash Flow:
$-8.86M
1W Performance:
+3.46%
1M Performance:
+52.84%
6M Performance:
-29.21%
1Y Performance:
+57.31%
1-Day Range:
$2.64
$2.91
1-Week Range:
$2.5506
$3.32
52-Week Range:
$1.15
$6.48
Inotiv Inc Stock (NOTV) Company Profile
Name
Inotiv Inc
Sector
Industry
Phone
(317) 463-4527
Address
2701 KENT AVE, WEST LAFAYETTE
Compare NOTV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NOTV
Inotiv Inc
|
2.69 | 96.19M | 501.06M | -99.22M | -8.86M | -3.84 |
|
TMO
Thermo Fisher Scientific Inc
|
401.90 | 152.41B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
196.02 | 136.31B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
524.91 | 41.46B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
115.80 | 32.18B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
152.32 | 24.40B | 15.50B | 1.33B | 2.16B | 7.34 |
Inotiv Inc Stock (NOTV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-14-24 | Downgrade | Jefferies | Buy → Hold |
| Feb-09-24 | Upgrade | Jefferies | Hold → Buy |
| Jul-20-23 | Initiated | Wells Fargo | Overweight |
| Jan-19-23 | Downgrade | Jefferies | Buy → Hold |
| Jan-11-23 | Upgrade | Lake Street | Hold → Buy |
| Nov-18-22 | Downgrade | Lake Street | Buy → Hold |
| Oct-04-22 | Initiated | Jefferies | Buy |
| Jan-31-22 | Initiated | Lake Street | Buy |
| Sep-20-21 | Initiated | Craig Hallum | Buy |
View All
Inotiv Inc Stock (NOTV) Latest News
Millennium Management LLC Increases Stock Holdings in Inotiv, Inc. (NASDAQ:NOTV) - Defense World
Inotiv, Inc. (NASDAQ:NOTV) Shares Sold by Ameriprise Financial Inc. - Defense World
Inotiv at Jefferies Global Healthcare: Strategic Growth and Stability By Investing.com - Investing.com South Africa
Inotiv at Jefferies Global Healthcare: Strategic Growth and Stability - Investing.com
Inotiv says it was told US SEC has closed bribery probe tied to primate imports - MLex
Inotiv discloses completion of SEC investigation (NOTV:NASDAQ) - Seeking Alpha
sec concludes investigation into inotiv, no enforcement action planned By Investing.com - Investing.com South Africa
Inotiv Cleared by SEC in Importation Probe - TipRanks
Northern Trust Corp Acquires 8,134 Shares of Inotiv, Inc. (NASDAQ:NOTV) - Defense World
Jefferies raises Inotiv stock price target on revenue growth outlook By Investing.com - Investing.com South Africa
Jefferies raises Inotiv stock price target on revenue growth outlook - Investing.com Australia
Inotiv Hosts 2025 Investor Day, Highlights Strategic Plans - TipRanks
Lazard Asset Management LLC Sells 9,230 Shares of Inotiv, Inc. (NASDAQ:NOTV) - Defense World
Inotiv, Inc. to Present at Jefferies Global Healthcare Conference 2025 - The Manila Times
Exclusive: Inotiv CEO Set for Strategic Update at Jefferies Healthcare Conference - Stock Titan
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Inotiv, Inc. (NOTV) Investors with Significant Losses to Contact the Firm’s Attorneys, Securities Fraud Class Action Filed - ACCESS Newswire
Dimensional Fund Advisors LP Has $131,000 Stock Position in Inotiv, Inc. (NASDAQ:NOTV) - Defense World
Inotiv outlines revised RMS site optimization plan with $6.5M investment and $6M-$7M annual savings projection - MSN
Inotiv, Inc. (NASDAQ:NOTV) Q2 2025 Earnings Call Transcript - Insider Monkey
Inotiv, Inc. (NOTV) Reports Q2 Loss, Tops Revenue Estimates - MSN
Inotiv, Inc. Earnings Call Highlights Revenue Growth - TipRanks
Inotiv (NOTV): Analyst Maintains Rating, Lowers Price Target | NOTV Stock News - GuruFocus
Inotiv quarterly loss narrows; site optimization efforts continue - Inside INdiana Business
Inotiv, Inc. SEC 10-Q Report - TradingView
Inotiv, Inc. Reports Improved Q2 Fiscal 2025 Results - TipRanks
Earnings call transcript: Inotiv Inc beats EPS forecast in Q2 2025 - Investing.com India
Inotiv Reports Second Quarter Financial Results for Fiscal 2025 and Provides Business Update - GlobeNewswire
Positive Sentiment Still Eludes Inotiv, Inc. (NASDAQ:NOTV) Following 29% Share Price Slump - simplywall.st
Inotiv, Inc. (NOTV) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - MSN
Inotiv, Inc. (NASDAQ:NOTV) Shares Sold by Geode Capital Management LLC - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Health Check: How Prudently Does Inotiv (NASDAQ:NOTV) Use Debt? - simplywall.st
Inotiv, Inc. to Report Fiscal 2025 Second Quarter Financial Results and Host Conference Call on Wednesday, May 7, 2025 - The Manila Times
Inotiv, Inc. to Release Fiscal 2025 Second Quarter Financial Results on May 7, 2025 - Nasdaq
Inotiv, Inc. to Report Fiscal 2025 Second Quarter Financial - GlobeNewswire
Inotiv Sets Q2 Earnings Release Date: Key Financial Results Coming May 7 After Market Close - Stock Titan
Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testing - Benzinga
Inotiv (NOTV) Faces Significant Shareholder Losses - GuruFocus
Sea Pharmaceuticals Partners with Inotiv for Pre-Clinical Studies on SPM-0404 - GuruFocus
Inotiv (NOTV) Plummets 50% as FDA Shifts Away from Animal Testing | CRL Stock News - GuruFocus
NOTV Stock Hits 52-Week Low at $1.2 Amid Market Challenges - Investing.com
Inotiv director sells $12,915 in common stock By Investing.com - Investing.com South Africa
Inotiv director sells $12,915 in common stock - Investing.com
Inotiv shareholders approve expanded equity incentive plan By Investing.com - Investing.com Australia
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Inotiv, Inc. (NOTV) Investors with Significant Losses to Contact the Firm’s Attorneys, Application Deadline Approaching in Securities Class Action - ACCESS Newswire
Inotiv shareholders approve expanded equity incentive plan - Investing.com
Market Cool On Inotiv, Inc.'s (NASDAQ:NOTV) Revenues Pushing Shares 32% Lower - Simply Wall St
2 Stocks Insiders Are Buying and 1 They're Selling - Benzinga
Shareholders in Inotiv (NASDAQ:NOTV) have lost 88%, as stock drops 33% this past week - Simply Wall St
Inotiv Inc Stock (NOTV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.40%
1.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):